Literature DB >> 19298742

Hysteroscopic polypectomy without cycle cancellation in IVF cycles.

Tahereh Madani1, Firouzeh Ghaffari, Kiandokht Kiani, Fatemeh Hosseini.   

Abstract

Endometrial polyps destroy the endometrial texture and play an important role in implantation failure. There is no consensus about the management of patients diagnosed with endometrial polyp in IVF cycles. In this study, nine patients who underwent assisted reproduction treatment cycles were diagnosed with endometrial polyps less than 1.5 cm by transvaginal ultrasonography. Eight patients were treated by long protocol and one patient was the recipient of an egg donation cycle. In all patients, polyp resection was performed through hysteroscopic polypectomy. Polypectomy was done during ovarian stimulation in the standard treatment cycles, and during hormone replacement therapy in the recipient of the egg donation cycle. The interval between polyp resection and embryo transfer was 2-16 days. Four patients achieved pregnancy (two twins, two singletons), four patients were unsuccessful, and one pregnancy was a blighted ovum. All of the successful pregnancies are still ongoing. There is a dilemma regarding the management of patients diagnosed with endometrial polyps in assisted reproduction treatment cycles. If polypectomy before embryo transfer in an IVF cycle is proven to be safe, then embryos will be transferred without cycle cancellation. This study included nine patients; further studies with more patients are required to confirm these findings.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19298742     DOI: 10.1016/s1472-6483(10)60101-0

Source DB:  PubMed          Journal:  Reprod Biomed Online        ISSN: 1472-6483            Impact factor:   3.828


  9 in total

Review 1.  Hysteroscopic polypectomy prior to infertility treatment: A cost analysis and systematic review.

Authors:  Youssef Mouhayar; Ophelia Yin; Sunni L Mumford; James H Segars
Journal:  Eur J Obstet Gynecol Reprod Biol       Date:  2017-04-13       Impact factor: 2.435

2.  A case report of bilateral tubal ectopic pregnancy following day 5 embryo transfer.

Authors:  Firouzeh Ghaffari; Poopak Eftekhari Yazdi; Kiandokht Kiani
Journal:  Arch Med Sci       Date:  2011-12-30       Impact factor: 3.318

Review 3.  Using fertile couples as embryo donors: An ethical dilemma.

Authors:  Leila Alizadeh; Reza Omani Samani
Journal:  Iran J Reprod Med       Date:  2014-03

4.  Assisted reproductive technique outcomes in hypogonadotropic hypogonadism women.

Authors:  Firouzeh Ghaffari; Arezoo Arabipoor; Narqes Bagheri Lankarani; Zhaleh Etminan; Ensieh Shahrokh Tehraninejad
Journal:  Ann Saudi Med       Date:  2013 May-Jun       Impact factor: 1.526

5.  The Effect of Endometrial Polyp Resection by Office Hysteroscopy during In Vitro Fertilization/Intracytoplasmic Sperm Injection Treatment Cycle on Pregnancy Rate A Series of 25 Cases.

Authors:  Firas Al Rshoud; Rami Kilani; Fida Al Asali; Omar Assi; Nedaa Ikhlaif; Ward Maaita
Journal:  J Hum Reprod Sci       Date:  2021-12-31

6.  Does hysteroscopic resection of polyps require cycle cancellation in women undergoing controlled ovarian hyperstimulation in the ICSI cycle?

Authors:  Serkan Oral
Journal:  Turk J Obstet Gynecol       Date:  2022-09-23

Review 7.  Surgical intervention versus expectant management for endometrial polyps in subfertile women.

Authors:  Kannamannadiar Jayaprakasan; Lukasz Polanski; Banchhita Sahu; Jim G Thornton; Nick Raine-Fenning
Journal:  Cochrane Database Syst Rev       Date:  2014-08-30

8.  Comparison of easy and difficult embryo transfer outcomes in in vitro fertilization cycles.

Authors:  Firouzeh Ghaffari; Kiandokht Kiani; Akram Bahmanabadi; Mohammadreza Akhoond
Journal:  Int J Fertil Steril       Date:  2013-03-03

9.  The effect of A1298c polymorphism of the MTHFR gene on anti-Müllerian hormone levels: experimental and Web-based analysis.

Authors:  Seyedeh Zahra Shahrokhi; Faranak Kazerouni; Firouzeh Ghaffari; Morteza Hadizadeh; Zahra Zolfaghary
Journal:  J Clin Lab Anal       Date:  2021-08-08       Impact factor: 2.352

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.